Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC) - Université de Bretagne Occidentale Access content directly
Journal Articles Oncotarget Year : 2018

Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC)

No file

Dates and versions

hal-02055888 , version 1 (04-03-2019)

Identifiers

  • HAL Id : hal-02055888 , version 1

Cite

Dominique Farge, Francis Cajfinger, Nicolas Falvo, Toufek Berremili, Francis Couturaud, et al.. Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC). Oncotarget, 2018, 9 (43). ⟨hal-02055888⟩
42 View
0 Download

Share

Gmail Facebook X LinkedIn More